Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704879 | SCV000235855 | benign | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000225715 | SCV000334580 | likely benign | not specified | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000473094 | SCV000560839 | benign | Duchenne muscular dystrophy | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426883 | SCV002681948 | benign | Cardiovascular phenotype | 2019-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Génétique et pathophysiologie de maladies neurodéveloppementales et épileptogènes, |
RCV000201326 | SCV000239946 | benign | Abnormality of neuronal migration | 2014-10-31 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001833102 | SCV002087689 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-10-08 | no assertion criteria provided | clinical testing |